Navigation Links
Semafore Broadens Pipeline With Multi-Targeted Kinase Inhibitors
Date:8/26/2008

aft models demonstrated 81 percent tumor growth inhibition. SF2506 testing resulted in 93 percent tumor growth reduction in the same model.

"Semafore's proprietary kinase scaffold and our new multi-targeted kinase inhibitors add significant value to our pipeline," said Dr. Dennis McKeever, Semafore's Chief Executive Officer. "In addition to inhibiting all Class I isoforms of PI3K, our compounds SF2506 and SF2523 block additional key kinases which is in keeping with the multi-targeting philosophy behind other recent successful molecularly targeted agents."

About Semafore

Semafore is a clinical stage drug discovery and development company focused on small molecule modulators of the PI3 kinase and PTEN cell signaling pathway, a promising target pathway for multiple disorders, including the company's focus -- cancer. Semafore is a leader in the development of PI3K inhibitors and one of the first biopharmaceutical companies to focus on both PI3K and PTEN. The company has successfully discovered and is developing a portfolio of drug candidates addressing these targets.

About SF1126

There is a strong and significant biological rationale for developing PI3 kinase inhibitors to treat cancer. Phosphoinositide 3-kinase (PI3K) is the gate keeper of one of the major pathways of intracellular signal transduction that regulates cell growth, proliferation, angiogenesis, migration, differentiation, and survival. Dysregulation of the PI3K signaling pathway is believed to play an integral role in the genesis of many cancers including both solid tumors and hematologic malignancies. Cancer research and pharmaceutical drug development efforts have been aimed at discovering and developing therapeutics that inhibit PI3K with the hope of controlling cancer cell division, angiogenesis (the formation of new blood vessels for cancer growth), proliferation and metastasis. Semafore's innovative PI3K inhibitor, SF1126, promises such hope for cancer patients. '/>"/>

SOURCE Semafore Pharmaceuticals Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Semafore Pharmaceuticals Reports Positive Interim Results from a Phase I Study of SF1126, a Targeted Pan-PI3K Inhibitor, in Patients with Advanced Solid Tumors
2. Semafores PI3 Kinase Inhibitor SF1126 is a Vascular Targeted Conjugate in Phase I Clinical Trials in Solid Tumors and Multiple Myeloma
3. Semafores SF1126 Exhibits Antitumor and Antiangiogenic Activity
4. Semafores PI3 Kinase Inhibitor SF1126 is Active Against Tumor and Tumor Cells and Synergizes with Standard Chemotherapy Agents
5. FDA Broadens US Indication for Once-Yearly Reclast(R) as Only Osteoporosis Treatment Approved for Prevention of Fractures After a Hip Fracture
6. Medarex Highlights Strength in Antibody Development and Underlying Pipeline Strategy at R&D Day Event in New York City
7. The Ocean Becomes a Pipeline To A Cure for Cystic Fibrosis
8. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
9. Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation
10. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
11. SuperGen to Highlight Oncology Pipeline Data in Multiple Presentations at the AACR Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 2014 Revenue and earnings above the ... and development In the past 2013/14 fiscal year ... percent to EUR 4.287 billion (last year: EUR 4.190 billion) ... to EUR 360 million. "Overall, 2013/14 was a successful fiscal ... , President and CEO of Carl Zeiss AG. "Thanks to ...
(Date:12/17/2014)... , The new ... of information concerning the biopharmaceutical Group,s national and international clinical ... to the recently launched institutional website that is receiving accolades ... by a new chapter in the fascinating story of Drug ... and panoramic hub on the world of clinical research, ranging ...
(Date:12/17/2014)... HOUSTON , Dec. 17, 2014 ... Autism Approved ( http://bit.ly/1382OkS ) program seal ... autism community. The program highlights medical practices, materials ... considered "autism-community friendly." Children affected by ... that can be exacerbated by ingredients found in ...
Breaking Medicine Technology:ZEISS Asserts its Position in Difficult Environment 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 2Dompé Offers a New "Window" on the World of Scientific Research, with the http://www.dompetrials.com Website, Dedicated to Clinical Trials 3Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 2Parents Of Children With Autism Spectrum Disorder Have New Options When Administering Medications 3
... 2, 2011 The Center for Radiation Therapy of ... patients in the Los Angeles area, has been awarded ... the result of a recent review by the American ... Radiation Oncology (ASTRO). Radiation oncology (radiation ...
... Va., March 2, 2011 Insmed Incorporated (Nasdaq: ... the one-for-10 reverse stock split of Insmed,s Common Stock ... 2, 2011, after the State Corporation Commission of the ... of Incorporation to effect the reverse stock split.  The ...
Cached Medicine Technology:The Center for Radiation Therapy of Beverly Hills Earns ACR-ASTRO Accreditation 2The Center for Radiation Therapy of Beverly Hills Earns ACR-ASTRO Accreditation 3One-for-10 Reverse Stock Split of Insmed Common Stock Becomes Effective 2
(Date:12/21/2014)... 2014 AngelWeddingDress.com’s new collection of 2015 ... total of 1,000 new designs in this collection, and ... 2015. , AngelWeddingDress.com promises to provide the ... wardrobe essentials while many fashion trends come and go. ... service team at AngelWeddingDress.com is ready to assist. ...
(Date:12/21/2014)... Recently, one of the best prom dresses online ... has introduced its new collection of 2015 prom dresses, ... all its prom dresses & other fashionable designs, up ... top quality dress products and great customer services to ... of the best prom dresses online shops around the ...
(Date:12/21/2014)... Serious Buyer, Andrew Hawley from Vintage ... and the Doors International Ballroom at the Hilton Hotel ... the only time that Morrison's mother would see her ... 1967. According to Hawley, “This would be the Doors ... Alexandria Roller Rink earlier that year and would return ...
(Date:12/21/2014)... December 21, 2014 SCI ... the issues and systemic barriers for disabled athletes with ... Champion. Scheidies has a condition called juvenile macular degeneration, ... describes how he adapted his athletic ambitions to his ... success in triathlon to pioneer the way for other ...
(Date:12/21/2014)... December 21, 2014 CannabisClassifieds.com celebrates marijuana’s new ... The only one of its kind, the site has provided ... marijuana for 14 years running. It uniquely combines the ... make cannabis readily available to the masses. Assuring the ... the golden ring of public approval. , Shane ...
Breaking Medicine News(10 mins):Health News:2015 Spring Wedding Dresses From AngelWeddingDress Just Released 2Health News:New Prom Dresses From One Of The Best Prom Dresses Online Shops, LunaDress Prom Shop 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2
... years back Dr Stephen Elliott was the radiologist consultant ... were expressed by Department of Health chiefs about the ... hospital authorities made his payment and also reduced his ... prompted by concerns raised by clinical staff in Antrim ...
... and alcohol team is now appointed to chair the Scottish ... Scotland suffers from an increase in the number of people ... as the head of SAADAT at the first meeting of ... a group which consists of both the former Scottish Association ...
... asked the pharmaceuticals companies and academic institutions to reveal all ... drug trails including the details about Phase I trials, initial ... be registered on independent registers as soon as they begin. ... is to spark mixed reaction among the researchers. ...
... many people’s problems comes a theory that tells why people ... studied brain scans to elucidate that there are centres in ... ads featuring food and packets of food product. , ... is likely that people over-eating, and become obese. ...
... to prevent or reduce public smoking. This is another step ... money would pay for 100 enforcement officers in the province. ... enclosed spaces which is common to public. , ... would help the people to quit smoking, discourage young people ...
... that the deadly strain H5N1 strain of bird flu has ... in Siberia all infected with the H5N1 strain.// The regional ... from Omsk region. , The samples of the ... biotechnology centre Vektor, for inspection. Ilya Drozdov, the centre's general ...
Cached Medicine News:Health News:The persistent urge to eat: Loose control!!! 2
... The TL-100 uses technology that takes ... by automatically detecting and reading them. It ... recording the results, mark lenses as you ... contact lenses. Easy to use, the TL-100 ...
... The Kowa RC-XV3 camera is ... The automatic exposure system, ... sensitivity, the 2.5~300ws watt indication ... handling are the basic features ...
FF 450plus fundus camera for 35mm photography. Upgradeable basic instrument for brilliant image quality....
The new TRC-NW6 non-mydriatic retinal camera is the ideal instrument for the growing market in telemedicine and diabetic screening....
Medicine Products: